Catalyst Pharmaceuticals (CPRX) EGM 2026 summary

Opening remarks and agenda

• Meeting commenced with instructions for participation and a welcome from the board chair.

• Agenda included voting on three specific proposals as outlined in the proxy statement.

Board and executive committee updates

• Introductions of all board members and executive officers were made at the start of the meeting.

Corporate governance

• The chairperson was authorized to preside and set meeting procedures per the company's bylaws.

• The record date for voting was set as June 3, 2026, and all required notices and proxy materials were confirmed as mailed.

• Inspector of Election was appointed and sworn in, with responsibilities for vote canvassing and reporting.

• Quorum was confirmed with a majority of shares represented.